Market revenue in 2023 | USD 22.8 million |
Market revenue in 2030 | USD 47.7 million |
Growth rate | 11.1% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 52.19% in 2023. Horizon Databook has segmented the China deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
According to Population Reference Bureau (PRB), the number of people belonging to the age group of 65 and above in China may increase to more than 300 million by 2050. Furthermore, China is developing cost-effective devices for individuals suffering from brain-associated diseases.
For instance, a China-based company called PINS Medical has developed a brain stimulation device commonly known as a brain pacemaker. PINS Medical was the first company to obtain a CE mark and has helped a number of individuals with movement disorders such as PD.
Therefore, such advancements in brain stimulation devices are likely to aid in creating growth opportunities in China deep brain stimulation devices market. The market may witness significant growth owing to strategic collaborations with global players for development as well as marketing of these devices due to the presence of high untapped opportunities in the country.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account